Evolution of calcium antagonists: Past, present, and future

Clinical Cardiology

Volumn 26, Issue 2 SUPPL., 2003, Pages

  Messerli, Franz H ^a  

^a OCHSNER CLINIC FOUNDATION   (United States)

Author keywords

Antihypertensive agents; Calcium antagonists; Diabetes; Hypertension; Lercanidipine; Pedal edema

Indexed keywords

CALCIUM ANTAGONIST; DIHYDROPYRIDINE DERIVATIVE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; LERCANIDIPINE; LOSARTAN; NIFEDIPINE; NITRENDIPINE; VERAPAMIL;

ADRENERGIC STIMULATION; CHINA; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; EDEMA; EUROPE; HEART LEFT VENTRICLE HYPERTROPHY; HEMODYNAMICS; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; META ANALYSIS; MORTALITY; MULTICENTER STUDY; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC HYPERTENSION; VASODILATATION;

EID: 17344382220     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960261405     Document Type: Conference Paper

References (26)

1. Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenhager WH, Bulpitt CJ, de Leeuw PW, Dollery CT, Fletcher AE, Forette F, Leonetti G, Nachev C, O'Brien ET, Rosenfeld J, Rodicio JL, Tuomilehto J, Zanchetti A: Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet 1997;350:757-764
2. Staessen JA, Thijs L, Birkenhager WH, Bulpitt CJ, Fagard R: Update on the systolic hypertension in Europe (Syst-Eur) trial. The Syst-Eur Investigators. Hypertension 1999;33:1476-1477
3. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (also available at: www.ama-assn.org/intemal). Arch Intern Med 1997; 157:2413-2446
4. Woods DJ, Fowler S: Nifedipine for hypertensive emergencies. J Am Med Assoc 1997;277:790-791
5. Grossman E, Messerli FH, Goldbourt U: High blood pressure and diabetes mellitus: Are all antihypertensive drugs created equal? Arch Intern Med 2000;160:2447-2452
6. UK Prospective Diabetes Study Group: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. Br Med J 1998;317:703-713
7. Furberg CD, Psaty BM, Meyer JV: Nifedipine. Dose-related increase in mortality in patients with coronary heart disease. Circulation 1995;92:1326-1331
8. Estacio RO, Jeffers BW, Hiatt WR, Biggerstaff SL, Gifford N, Schrier RW: The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension. N Engl J Med 1998;338:645-652
9. Tatti P, Pahor M, Byington RP, Di Mauro P, Guarisco R, Strollo G, Strollo F: Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM. Diabetes Care 1998;21:597-603
10. Abernethy DR, Schwartz JB: Calcium-antagonist drugs. N Engl J Med 1999;341:1447-1457
11. Pahor M, Kritchevsky SB, Zuccala G, Guralnik JM: Diabetes and risk of adverse events with calcium antagonists. Diabetes Care 1998;21:193-194
12. Tuomilehto J, Rastenyte D, Birkenhager WH, Thijs L, Antikainen R, Bulpitt CJ, Fletcher AE, Forette F, Goldhaber A, Palatini P, Sarti C, Fagard R: Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators. N Engl J Med 1999;340:677-684
13. Wang JG, Staessen JA, Gong L, Liu L: Chinese trial on isolated systolic hypertension in the elderly. Systolic Hypertension in China (Syst-China) Collaborative Group. Arch Intern Med 2000;160: 211-220
14. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs. diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). J Am Med Assoc 2002;288:2981-2997
15. Schmieder R: Reduction of left ventricular hypertrophy (LVH) by antihypertensive therapy: results of a meta-analysis of all doubleblind randomized studies. J Am Coll Cardiol 2001;37(suppl 2): 261A-262A
16. Gerritsen TA, Bak AA, Stolk RP, Jonker JJ, Grobbee DE: Effects of nitrendipine and enalapril on left ventricular mass in patients with non-insulin-dependent diabetes mellitus and hypertension. J Hypertens 1998;16:689-696
17. Fogari R, Mugellini A, Corrao S, Preti P, Zoppi A, Lazzari P, Pasotti M: Efficacy of lercanidipine vs. losartan on left ventricular hypertrophy in hypertensive type 2 diabetic patients. J Hypertens 2000; 18(suppl 2):S65
18. Elliott WJ: Drug therapy and "dropouts" in a tertiary hypertension clinic (abstr). Am J Hypertens 1994;7:26A
19. Chrysant SG, Cohen M: Sustained blood pressure control with controlled-release isradipine. Am J Hypertens 1995;8:87-89
20. Messerli FH: Vasodilatory edema: A common side effect of antihypertensive therapy. Am J Hypertens 2001;14:978-979
21. Weir MR: The rationale for combination versus single-entity therapy in hypertension. Am J Hypertens 1998;11:163S-169S
22. Messerli FH: Vasodilatory edema: A common side effect of antihypertensive therapy. Curr Cardiol Rep 2002;4:479-482
23. Borghi C, Prandin MG, Dormi A, Bacchelli S, Degli Esposti D, Ambrosioni E: The use of lercanidipine can improve the individual tolerability to dihydropiridine calcium blockers in hypertensive patients. J Hypertens 2000;18(suppl 2):S155
24. Fogari R, Malamani GD, Zoppi A, Preti P, Vanasia A, Fogari E, Mugellini A: Comparative effect of lercanidipine and nifedipine gastrointestinal therapeutic system on ankle volume and subcutaneous interstitial pressure in hypertensive patients: A double-blind, randomized, parallel-group study. Curr Ther Res Clin Exp 2000;61: 850-862
25. Leonetti G,Magnani B, Pessina AC, Rappelli A, Trimarco B, Zanchetti A, on behalf of the COHORT Study Group: Tolerability of long-term treatment with lercanidipine vs. amlodipine and lacidipine in elderly hypertensives. Am J Hypertens 2002;15:932-940
26. Sabbatini M, Leonardi A, Testa R, Vitaioli L, Amenta F: Effect of calcium antagonists on glomerular arterioles in spontaneously hypertensive rats. Hypertension 2000;35:775-779